Ocean Biomedical Company Insiders

Ocean Biomedical Management Team Effectiveness

The company has return on total asset (ROA) of (6.8199) % which means that it has lost $6.8199 on every $100 spent on assets. This is way below average. Ocean Biomedical's management efficiency ratios could be used to measure how well Ocean Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ocean Biomedical's Return On Tangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0, whereas Return On Capital Employed is projected to grow to (0.03). At present, Ocean Biomedical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 133.4 M, whereas Net Tangible Assets are projected to grow to (5.7 M). As of November 21, 2024, Common Stock Shares Outstanding is expected to decline to about 24.8 M. The current year's Net Loss is expected to grow to about (53.3 M)

Ocean Biomedical Workforce Comparison

Ocean Biomedical Insider Trading

Ocean Biomedical Notable Stakeholders

The success or failure of an entity such as Ocean Biomedical often depends on how effective the management is. Ocean Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ocean management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ocean management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Ocean Biomedical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ocean Biomedical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ocean Biomedical's management manipulating its earnings.

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.